Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550483/
https://www.ncbi.nlm.nih.gov/pubmed/37799648
http://dx.doi.org/10.1155/2023/9806864
_version_ 1785115549641998336
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10550483
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105504832023-10-05 Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-09-27 /pmc/articles/PMC10550483/ /pubmed/37799648 http://dx.doi.org/10.1155/2023/9806864 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title_full Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title_fullStr Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title_full_unstemmed Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title_short Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
title_sort retracted: clinical observation and pharmacoeconomic evaluations of original research drug and generic drug bortezomib in the treatment of multiple myeloma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550483/
https://www.ncbi.nlm.nih.gov/pubmed/37799648
http://dx.doi.org/10.1155/2023/9806864
work_keys_str_mv AT healthcareengineeringjournalof retractedclinicalobservationandpharmacoeconomicevaluationsoforiginalresearchdrugandgenericdrugbortezomibinthetreatmentofmultiplemyeloma

Ejemplares similares